Sustabol 350 by British Dragon

A single-ester compound provides one release profile — Enanthate begins active at approximately 3–5 days after injection and maintains elevated levels for 10–14 days. A four-ester blend provides active testosterone from four overlapping release windows simultaneously. The Propionate component elevates testosterone within 24–48 hours — before Enanthate would register significantly — while the Decanoate component sustains baseline levels through week 2–3. The practical consequence is that Sustabol 350 cycles achieve effective anabolic conditions in the first week rather than the second, and maintain more consistent testosterone coverage as the longer esters continue releasing after the shorter ones have cleared. For athletes prioritising stable early onset alongside long-cycle sustained release from a single twice-weekly injection, the blend offers a pharmacokinetic profile no single ester can replicate.

The Testosterone Propionate component (42 mg per ml) has a half-life of 1–2 days — it creates a measurable peak within the first 24–48 hours of injection and then declines rapidly. On a once-weekly schedule, this Propionate peak-and-decline cycle introduces greater testosterone variability than a pure Enanthate protocol would at the same frequency. Twice-weekly injections — spaced every 3–4 days — mean the next injection arrives before the Propionate peak has fully cleared and while the Decanoate ester is still building, producing a smoother cumulative plasma curve. Athletes who must inject once weekly can do so effectively, but should expect more pronounced peak-trough variation and may need more attentive estrogen management around injection days.

Standard Sustanon 250 contains 250 mg of total testosterone per millilitre. Sustabol 350 contains 350 mg per millilitre — a 40% increase in testosterone delivered per unit of injection volume. The ester composition ratios are the same; the concentration is higher. For athletes targeting 700 mg/week, Sustabol 350 requires 2 ml per injection (twice weekly), while Sustanon 250 requires approximately 2.8 ml — approaching the volume tolerance limit for many injection sites. The higher concentration is a practical advantage for athletes at the upper end of the performance dose range, where minimising injection volume per dose reduces site irritation and scar tissue accumulation across a long cycle.

Post-cycle therapy with SERMs (Clomiphene, Tamoxifen) works by stimulating LH and FSH release from the pituitary — but this stimulation is suppressed as long as significant exogenous testosterone remains active in the system. Beginning PCT while substantial testosterone is still circulating produces no meaningful LH/FSH response. The Testosterone Decanoate ester — the largest single component of Sustabol 350 at 140 mg per ml — has a half-life of 15–18 days, meaning measurable active levels persist for approximately 3 weeks after the final injection. Starting PCT at day 3 or day 7 (appropriate for Propionate or Enanthate respectively) would be premature with Sustabol 350. The 21-day wait allows the Decanoate to clear sufficiently for SERM therapy to produce the endogenous testosterone recovery it is prescribed to achieve.

Yes — testosterone is the standard recommendation for a first injectable cycle precisely because it is the compound the body produces naturally, its effects are well characterised, its side effects are well understood, and its management tools (AIs, SERMs) are established. Sustabol 350 as a first injectable is slightly more complex than a pure Testosterone Enanthate first cycle because the four-ester pharmacokinetic profile requires understanding the injection frequency rationale and PCT timing considerations unique to the blend. A first-cycle athlete should be comfortable with the 21-day post-cycle clearance requirement before PCT, the twice-weekly injection schedule, and AI management calibration. For athletes who want the simplest possible first-cycle protocol, Testabol Enanthate (single ester, predictable flat release profile, 14-day PCT delay) is marginally more straightforward. For athletes who want faster cycle onset without daily injection, Sustabol 350 is the practical first-injectable choice.

Most users notice the first effects within the first one to two weeks of dosing.

The side profile depends on the compound class - the Side Effects section on the product page above covers the exact watchpoints for sustabol.

Oral compounds clear within days of the last dose; injectable esters extend detection to weeks or months depending on the ester.

British Dragon Sustabol 350 is available in this shop with international and domestic shipping.